Prediction of Appropriate Implantable Cardioverter-Defibrillator Therapy Using Machine Learning and Routinely Available Clinical Data
Abstract Background and Aims Risk stratification for appropriate implantable cardioverter-defibrillator (ICD) therapy remains imprecise when based on conventional clinical variables alone. We aimed to develop and geographically validate a machine-learning model that integrates routinely available clinical, electrocardiogram, and device interrogation/programming parameters, and quantify the incremental value of non-sustained ventricular tachycardia (NSVT). Methods We retrospectively analysed 514 ICD recipients implanted between 2020 and 2025 at two hospital sites (development cohort) and an independent cohort of 220 patients from a third site (external validation). The endpoint was appropriate ICD therapy (anti-tachycardia pacing or shock). Models were trained using nested stratified cross-validation in the development cohort, and the final refitted model was applied to the external cohort without recalibration. Results In the development cohort, 77/514 patients (15%) experienced appropriate ICD therapy (follow-up 404 days). A base model (Histogram-based gradient boosting) excluding NSVT achieved modest discrimination (ROC-AUC 0.624; average precision 0.198). Adding NSVT improved performance (ROC-AUC 0.805; average precision 0.432). Logistic regression with NSVT achieved comparable discrimination (ROC-AUC 0.78; average precision 0.43), indicating a largely NSVT-driven gain. External validation (event rate 51/220, 23%) confirmed good discrimination (ROC-AUC 0.815; average precision 0.583) with acceptable calibration (Brier score 0.137). At prespecified threshold 0.16 in external validation, sensitivity was 0.78 and specificity 0.74. Conclusion A machine-learning model integrating routinely available clinical, electrocardiogram, and ICD programming/interrogation data may enable prediction of appropriate ICD therapy with preserved performance on geographic external validation. NSVT was the dominant contributor to predictive performance across modelling approaches.
Authors
- Toshinori Chiba (ORCID: https://orcid.org/0000-0002-2173-4519)
- Emanuel Heil (ORCID: https://orcid.org/0000-0001-9782-8311)
- Verena Tscholl (ORCID: https://orcid.org/0000-0003-2748-2540)
- Robert Hättasch (ORCID: https://orcid.org/0000-0001-6276-0847)
- Johannes Lucas
- Gerhard Hindricks (ORCID: https://orcid.org/0000-0002-0132-0773)
- Patrick Nagel
- Felix Hohendanner (ORCID: https://orcid.org/0000-0002-0194-4615)
- Felix Balzer (ORCID: https://orcid.org/0000-0003-1575-2056)
- Nikolaos Dagres (ORCID: https://orcid.org/0000-0003-0323-4956)
- Wilhelm Haverkamp (ORCID: https://orcid.org/0000-0002-6183-2519)
- Alexander Meyer (ORCID: https://orcid.org/0000-0002-6944-2478)
- F Blaschke
- S Wegner
Institutions
- Humboldt-Universität zu Berlin (DE)
- Deutsches Herzzentrum der Charité (DE)
- German Centre for Cardiovascular Research (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- European Heart Journal - Digital Health
- Published
- 2026-06-25
- DOI
- https://doi.org/10.1093/ehjdh/ztag102
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00